|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
+4.17% | +9.89% |
| 03/06 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 01/06 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Drug Stores and Pharmacies | |||||
Wholly Owned Pharmacies | - | - | - | 28.04L | 1.47Cr |
Gross Profit | - | - | - | 10.42L | 57L |
Operating Income | - | - | - | 3L | 18.43L |
Non-wholly Owned Pharmacies | - | - | - | 29.91L | 62.39L |
Total Assets | 10.01L | 27.33L | 23.21L | - | - |
EBT | -25.82T | -5L | -5L | - | - |
Gross Profit | - | - | - | 11.42L | 25.99L |
Operating Income | - | - | - | 2L | 7L |
Net Income | -25.82T | -5L | -5L | - | - |
Operating Income | - | - | - | -21.24L | -37.91L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Canada | - | - | - | 57.95L | 2.09Cr |
Total Assets | 10.01L | 27.33L | 23.21L | 3.52Cr | 6.56Cr |
Interest Expense | - | - | - | -14.26T | -56.86T |
Income Tax Expense | - | - | - | -1L | 6L |
D&A | - | - | - | 3L | 9L |
CAPEX | - | - | - | -6.89T | -87.6T |
Gross Profit | - | - | - | 21.84L | 82.98L |
Net Income | -25.82T | -5L | -5L | -10.13L | -14.81L |
EBT | -25.82T | -5L | -5L | -11.57L | -8L |
Operating Income | - | - | - | -16.03L | -12.95L |
- Stock Market
- Stocks
- PCRX Stock
- Financials PharmaCorp Rx Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
